-
公开(公告)号：US20230338654A1
公开(公告)日：2023-10-26
申请号：US18139427
申请日：2023-04-26
Applicant: Dexcom, Inc.
Inventor： Stephen D. Patek , Matthew S. Gerber , Enrique Campos-Nanez , Thibault Gautier , Leah Ziegler
CPC classification number: A61M5/1723 , A61M5/16877 , A61M2202/0486 , A61M2205/50
Abstract: A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.
-
2.发明申请公开(公告)号：US20220152313A1
公开(公告)日：2022-05-19
申请号：US17452885
申请日：2021-10-29
Applicant: DexCom, Inc.
Inventor： Lauren Hruby Jepson , Leah Ziegler
Abstract: This application relates to a medicament delivery device such as medicament injection pen that can distinguish between a priming dosage and the injection of therapeutic dosage into a patient. In one aspect, the medicament injection device includes a housing having a chamber configured to contain a cartridge of medicament, and a dose setting and dispensing mechanism configured to set and dispense a dose of the medicament from the cartridge. The device may also include a logging module configured to detect and record as a pen event a dispensed volume of a medicament dose and a time when the medicament dose is dispensed. The device may further include a dose distinguisher configured to distinguish between pen events associated with priming doses and pen events associated with therapeutic doses based at least in part on historical user data identifying pen events as a therapeutic pen event or a priming pen event.
-
公开(公告)号：US20240058532A1
公开(公告)日：2024-02-22
申请号：US18383133
申请日：2023-10-24
Applicant: Dexcom, Inc.
Inventor： Stephen D. Patek , Matthew S. Gerber , Enrique Campos-Nanez , Thibault Gautier , Leah Ziegler
CPC classification number: A61M5/1723 , A61M5/16877
Abstract: A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.
-
公开(公告)号：US20210205534A1
公开(公告)日：2021-07-08
申请号：US17131364
申请日：2020-12-22
Applicant: DexCom, Inc.
Inventor： Lauren Hruby Jepson , Alexandra Elena Constantin , Matthew T. Vogel , Christopher Robert Hannemann , Todd N. Haseyama , Apurv Ullas Kamath , Sarah Kate Pickus , Stephen J. Vanslyke , Kamuran Turksoy , Ghazaleh R. Esmaili , Leah Ziegler
Abstract: Various examples are directed to systems and methods for generating a bolus dose for a host. A bolus application may display a first bolus configuration parameter question at a user interface and receive, through the user interface, a first answer to the first bolus configuration parameter question. The first answer may describe a previous bolus determination technique of the host. The bolus application may select a second bolus configuration parameter question using the first answer and provide the second bolus configuration parameter question at the user interface. The bolus application may determine a set of at least one bolus configuration parameter using the first answer and a second answer to the second bolus configuration parameter question.
-
-
-
Search Results
4
records
(took 0.009 seconds)
